MDS Nordion teams with Avid Radiopharmaceuticals

Guest Contributor
April 10, 2007

MDS Nordion, Ottawa, is collaborating with Avid Radiopharmaceuticals Inc, Philadelphia PA, to conduct clinical trials for Avid's radiopharmaceuticals designed to diagnose and monitor Alzheimer's disease. MDS Nordion will radiolabel Avid compounds for use in proof-of-concept clinical trials for Avid's single proton emission computed tomography (SPECT) molecular imaging technology….

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.